Fortrea Holdings FTRE
NASDAQ FTRE
$20.29 +0.32 (+1.60%)
As of: Sep 17, 2026 · 3:59 PM EDT

Fortrea Holdings (FTRE) Liabilities and Shareholders Equity (2022 - 2026)

Fortrea Holdings' (FTRE) quarterly Liabilities and Shareholders Equity came in at $2.7 billion in Q2 2026, down 4.24% on a YoY basis from $2.8 billion in Q2 2025, and up 1.17% quarter-over-quarter from $2.7 billion in Q1 2026.

Analysis

Fortrea Holdings (FTRE) Liabilities and Shareholders Equity (2022 - 2026) Analysis & Trends

Fortrea Holdings (FTRE) has reported Liabilities and Shareholders Equity for 5 consecutive years, with $2.7 billion the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Liabilities and Shareholders Equity fell 4.24% year-over-year to $2.7 billion; the trailing twelve-month figure through Jun 2026 stood at $10.9 billion (down 17.75% YoY), and the FY2025 full-year result was $2.7 billion, down 24.13% from the prior year.
  • Liabilities and Shareholders Equity grew to $2.7 billion in Q2 2026 per FTRE's latest filing, from $2.7 billion in the prior quarter.
  • Across five years, Liabilities and Shareholders Equity topped out at $4.4 billion in Q2 2023 and bottomed at $2.7 billion in Q1 2026.
  • Historically, Liabilities and Shareholders Equity has averaged $3.5 billion across 5 years, with a median of $3.6 billion in 2024.
  • The sharpest annual moves came in 2023 and 2025: Liabilities and Shareholders Equity grew 1.04% in 2023, then retreated 26.39% in 2025.
  • Over 5 years, Liabilities and Shareholders Equity stood at $4.3 billion in 2022, then climbed by 1.04% to $4.3 billion in 2023, then retreated by 17.39% to $3.6 billion in 2024, then decreased by 24.13% to $2.7 billion in 2025, then decreased by 0.03% to $2.7 billion in 2026.
  • According to Business Quant data, Liabilities and Shareholders Equity over the past three periods registered $2.7 billion, $2.7 billion, and $2.7 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Iqvia Holdings 44.72 Bn 42.64 Bn 1.44 Bn 29.88 Bn
2 Medpace Holdings 17.37 Bn 16.87 Bn 201.64 Mn 2.06 Bn
3 Icon 13.65 Bn 12.72 Bn 479.29 Mn 16.40 Bn
4 Charles River Laboratories International 13.13 Bn 12.94 Bn 452.07 Mn 7.53 Bn
5 Fortrea Holdings 1.89 Bn 1.72 Bn 139.20 Mn 2.71 Bn
6 Evotec SE 574.75 Mn 148.87 Mn - 1.83 Bn
7 Ginkgo Bioworks Holdings 439.63 Mn 355.09 Mn 18.44 Mn 990.05 Mn
8 Champions Oncology 69.43 Mn 65.03 Mn 7.70 Mn 33.29 Mn
9 MindWalk Holdings 51.76 Mn 46.29 Mn 1.61 Mn 12.42 Mn
10 VivoSim Labs 1.37 Mn 1.37 Mn - 3.85 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.71 Bn
Mar 31, 2026 2.68 Bn
Dec 31, 2025 2.72 Bn
Sep 30, 2025 2.74 Bn
Jun 30, 2025 2.84 Bn
Mar 31, 2025 3.12 Bn
Dec 31, 2024 3.58 Bn
Sep 30, 2024 3.66 Bn
Jun 30, 2024 3.57 Bn
Mar 31, 2024 4.24 Bn
Dec 31, 2023 4.33 Bn
Sep 30, 2023 4.32 Bn
Jun 30, 2023 4.36 Bn
Dec 31, 2022 4.29 Bn